Innovative Pharmacy Program Enhances Colorectal Cancer Awareness
Workflow Services Expands Colorectal Cancer Screening Education
Workflow Services, a leading platform designed for pharmacist-led clinical solutions, has recently announced a significant development in its efforts to promote awareness and access to preventive healthcare. The company has successfully completed a comprehensive one-year pilot program that demonstrates the effectiveness of community pharmacies in educating patients about the critical importance of colorectal cancer screening.
Colorectal cancer remains a serious health concern, ranking as the second leading cause of cancer-related fatalities in the United States. However, early detection dramatically improves treatment outcomes, with approximately 90% of cases being highly treatable. Through this expansion of its education program, Workflow Services aims to address the gaps in preventive care utilization, leveraging the trusted relationship pharmacists have with their communities to amplify health awareness.
An alarming statistic highlights the challenge: 25% of Americans do not have a primary care provider. This lack of access can lead to patients missing vital health screenings. In contrast, 90% of Americans reside within five miles of a community pharmacy. Therefore, pharmacists are uniquely positioned to serve as reliable sources of healthcare information, bridging the gap and facilitating essential education on important health screenings such as those for colorectal cancer.
In the pilot program, an impressive 92% of participating pharmacists reported improved confidence in educating patients about colorectal cancer screening. Kevin Houlihan, the President and CEO of Workflow Services, emphasized this breakthrough. He stated, "The data we collected during the pilot clearly indicates that we are unlocking a new, impactful channel within healthcare. Access to care is a pressing challenge in our healthcare system, and our platform equips pharmacists with the necessary tools to effectively address care gaps and promote better health outcomes for the communities they serve."
As a result of the pilot's success, pharmacies nationwide can now integrate the Workflow Services platform into their patient interactions, including colorectal cancer screening education as part of routine health discussions. This initiative provides pharmacists with a reliable and efficient method to facilitate proactive health measures, empowering patients to take charge of their health.
Rebecca Liggon, PharmD and Director of Pharmacy Engagement at Workflow Services, pointed out the practicality of this program by stating, "Our solution is designed to minimize the burden on pharmacy staff. It allows pharmacists to support colorectal cancer screening initiatives with ease while receiving comprehensive training and resources to bolster their efforts." Such innovative approaches ensure that health education is seamlessly woven into the fabric of everyday pharmacy practice.
The American Cancer Society advocates for early screening for colorectal cancer starting at age 45 for individuals with average risk factors. Through this initiative, Workflow Services not only targets enhanced screening but also aims to alleviate the workforce challenges pharmacies face in delivering critical health services.
About Workflow Services
Workflow Services is committed to empowering pharmacies to realize their potential as central healthcare destinations within their communities. The company's advanced software solutions facilitate the secure capturing and integration of medical data, thereby enhancing communication and improving patient care. In a groundbreaking partnership in 2023, the Food and Drug Administration (FDA) appointed Workflow Services as a collaborator in its Diagnostic Data Program, marking a significant step toward standardizing data collection from point-of-care tests conducted in pharmacy settings. To learn more about the company's initiatives, interested parties can explore their digital platforms.
Media Contact:
John Flaherty
(773) 799-8200
Frequently Asked Questions
What is the purpose of the Workflow Services program?
The program aims to educate patients about colorectal cancer screening and improve preventative care access through pharmacies.
How does the program benefit community pharmacies?
It enables pharmacies to become key health education hubs, promoting proactive healthcare conversations and screenings.
What statistics support colorectal cancer screening effectiveness?
When detected early, colorectal cancer can be treated successfully in about 90% of cases, highlighting the need for regular screenings.
At what age does the American Cancer Society recommend screening to begin?
The American Cancer Society recommends starting colorectal cancer screenings at age 45 for individuals with average risk factors.
How does Workflow Services make it easier for pharmacists?
Their platform provides the necessary tools, resources, and training to facilitate effortless integration of screening education into pharmacy practices.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
